Wound Care (Pharmacies) - Egypt

  • Egypt
  • Revenue in the Wound Care market is projected to reach US$1.27m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.78%, resulting in a market volume of US$1.32m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.01 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Egypt is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory. Customer preferences in the Wound Care (Pharmacies) market in Egypt are shifting towards more advanced and innovative products. Consumers are increasingly seeking wound care products that provide faster healing, reduced scarring, and improved overall wound management. This preference for advanced products is driven by the growing awareness of the importance of proper wound care and the desire for quicker recovery times. Additionally, consumers are also looking for products that are easy to use and convenient to purchase, making pharmacies an ideal distribution channel. In terms of trends in the market, there is a growing demand for wound care products in Egypt due to several factors. Firstly, the country has a large population with a high prevalence of chronic diseases such as diabetes, which can lead to slow-healing wounds. This creates a significant market opportunity for wound care products. Secondly, there is an increasing focus on healthcare infrastructure and services in Egypt, with the government investing in the expansion of healthcare facilities and the improvement of healthcare quality. This has led to a greater availability and accessibility of wound care products in pharmacies across the country. Local special circumstances also contribute to the development of the Wound Care (Pharmacies) market in Egypt. The country has a well-established network of pharmacies, making it easy for consumers to access wound care products. Pharmacies in Egypt also play a crucial role in providing healthcare services and advice, making them a trusted source for wound care products. Additionally, the Egyptian government has implemented regulations and quality standards for pharmaceutical products, ensuring the safety and efficacy of wound care products available in the market. Underlying macroeconomic factors further support the growth of the Wound Care (Pharmacies) market in Egypt. The country has been experiencing economic stability and steady GDP growth, which has led to an increase in disposable income and consumer spending. This allows consumers to afford and prioritize healthcare products, including wound care products. Furthermore, the government's focus on healthcare infrastructure development and investment in the pharmaceutical sector creates a favorable environment for the growth of the market. In conclusion, the Wound Care (Pharmacies) market in Egypt is developing due to customer preferences for advanced products, growing demand driven by the prevalence of chronic diseases, the well-established network of pharmacies, government regulations and quality standards, and the overall macroeconomic factors supporting the healthcare sector. This positive trajectory presents opportunities for both local and international players in the market to meet the evolving needs of consumers and contribute to the improvement of wound care in the country.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)